CD8A and neoplasm: As expected, ABZ-treated CD73 KO mice showed further decreased PD-L1 expression levels in the B16F10 and LLC subcutaneous tumor regions (figure 4L, M) and increased proportions of infiltrated CD8+ and GZMB+ CD8+ T cells in the tumor region (figure 4N, O, online supplemental figure 5A-D).